Gemcitabine Hydrochloride for Injection 1g

• Customization: Available
• Package: 1vials/Box
• Composition: Gemcitabine
• Model NO.: 1g
• Transport Package: Free
• Specification: 1g
• Trademark: Sinolead
• Origin: China

Product Description

Product	Dose	Package
Gemcitabine Hydrochloride For Injection	1g	1vials/box

• Gemcitabine Hydrochloride for Injection contains gemcitabine, a nucleoside analog that disrupts DNA synthesis and cell division, leading to inhibition of cancer cell growth and proliferation. It is formulated as a sterile powder for reconstitution and intravenous administration.

Indications:
 

Gemcitabine Hydrochloride for Injection is indicated for the treatment of various cancers, including:

Pancreatic cancer: It is commonly used as a first-line treatment or in combination with other chemotherapy agents for advanced or metastatic pancreatic cancer.

Non-small cell lung cancer (NSCLC): It may be used as a single agent or in combination with other drugs for the treatment of advanced NSCLC.

Breast cancer, ovarian cancer, bladder cancer, and other solid tumors: It may be used in the treatment of these malignancies, either alone or in combination with other chemotherapy agents.

 

Dosage and Administration:

Gemcitabine Hydrochloride for Injection is reconstituted with sterile water for injection to form a solution for intravenous infusion. The dosage and administration schedule depend on factors such as the type and stage of cancer, patient's overall health, and treatment response. It is administered by a healthcare professional in a clinical setting, with close monitoring for adverse effects.


Precautions and Consultation:

Prior to initiating treatment with Gemcitabine Hydrochloride for Injection, healthcare providers should assess the patient's medical history, performance status, and baseline laboratory values. Patients should be monitored closely for signs of adverse effects during and after treatment, with appropriate supportive care measures implemented as needed.